Skip to main content
  • Investors
  • Mediaopen in a new window
  • Contact Usopen in a new window
  • |
Ironwood Logoopen in a new window
  • Company
  • Science & Medicine
  • Patients
  • Responsibility
  • Careers
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
Close
Close
  • Investors
  • Company
  • Product
  • Research & Development
  • Patients
  • Partnerships
  • Careers
Close

Press Releases

Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
November 30, 2015
Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan
Download PDF format download (opens in new window)
November 30, 2015
Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation
Download PDF format download (opens in new window)
November 4, 2015
Ironwood Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare Conference
Download PDF format download (opens in new window)
November 3, 2015
Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update
Download PDF format download (opens in new window)
November 3, 2015
Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
Download PDF format download (opens in new window)
November 2, 2015
Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation
Download PDF format download (opens in new window)
October 27, 2015
Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries
Download PDF format download (opens in new window)
October 19, 2015
Ironwood Highlights Refractory GERD and Constipation Research at the American College of Gastroenterology 2015 Annual Scientific Meeting
Download PDF format download (opens in new window)
October 14, 2015
Ironwood Pharmaceuticals to Host Third Quarter 2015 Investor Update Call
Download PDF format download (opens in new window)
October 13, 2015
Ironwood Reports Positive Top-Line Results from Phase III Trial of 72 mcg Linaclotide in Adults with Chronic Idiopathic Constipation
Download PDF format download (opens in new window)
September 10, 2015
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Download PDF format download (opens in new window)
August 5, 2015
Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
Download PDF format download (opens in new window)
August 5, 2015
Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.
Download PDF format download (opens in new window)
July 22, 2015
Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973
Download PDF format download (opens in new window)
July 15, 2015
Ironwood Pharmaceuticals to Host Second Quarter 2015 Investor Update Call
Download PDF format download (opens in new window)
July 8, 2015
AstraZeneca and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Designed to Support Linaclotide Approval in China
Download PDF format download (opens in new window)
June 10, 2015
Ironwood Pharmaceuticals Prices $300 Million of Convertible Senior Notes
Download PDF format download (opens in new window)
June 8, 2015
Ironwood Pharmaceuticals Announces Proposed Offering of $300 Million of Convertible Senior Notes
Download PDF format download (opens in new window)
June 4, 2015
Ironwood Pharmaceuticals to Present at Goldman Sachs 36th Annual Global Healthcare Conference
Download PDF format download (opens in new window)
May 13, 2015
Ironwood Presents Gastrointestinal Disease Research at Digestive Disease Week® 2015
Download PDF format download (opens in new window)
May 7, 2015
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
Download PDF format download (opens in new window)
May 5, 2015
Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update
Download PDF format download (opens in new window)
April 16, 2015
Ironwood Pharmaceuticals Appoints Lawrence Olanoff, M.D., Ph.D., to Board of Directors
Download PDF format download (opens in new window)
April 15, 2015
Ironwood Pharmaceuticals to Host First Quarter 2015 Investor Update Call
Download PDF format download (opens in new window)
March 9, 2015
Exact Sciences and Ironwood Pharmaceuticals Enter Co-Promotion Agreement for Cologuard®
Download PDF format download (opens in new window)
March 5, 2015
Ironwood Pharmaceuticals Initiates Phase I Clinical Study of sGC Stimulator IW-1973
Download PDF format download (opens in new window)
March 4, 2015
Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Download PDF format download (opens in new window)
February 23, 2015
Ironwood Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference
Download PDF format download (opens in new window)
February 12, 2015
Ironwood Pharmaceuticals Provides Fourth Quarter 2014 Investor Update
Download PDF format download (opens in new window)
February 4, 2015
Ironwood Reports Positive Top-Line Data from Exploratory Phase IIa Trial Of IW-3718 in Refractory Gastroesophageal Reflux Disease
Download PDF format download (opens in new window)
January 29, 2015
Ironwood Pharmaceuticals to Host Fourth Quarter 2014 Investor Update Call
Download PDF format download (opens in new window)
January 5, 2015
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Email Alert Sign Up Confirmation

Ironwood Logoopen in a new window
  • Investors
  • Media
  • Contact us
Follow us on Linkedin Follow us on Twitter

COMPANY

  • Company Overview
  • Leadership
  • Open Payments & Transparecy

PRODUCT

  • Linzees

RESEARCH & DEVELOPMENT

  • Pipeline
  • Medical Affairs

PARTNERSHIPS

  • Overview
  • Grants

PATIENTS

  • Overview

RESPONSBILITY

  • Overview
  • Community Giving
  • Equity,Diversity & Inclusion
  • Sustainability
  • Safety & Compliance
  • Patients & Research

CAREERS

  • Working at Ironwood
  • Open Positions
  • Internships, Co-ops & Fellowships

INVESTORS

  • Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
  • Finanical Information
  • Investor FAQ
  • Press Releases
  • Investor Contacts
  • Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window)
  • Privacy Policy
  • California Privacy Policy
  • Site Map
  • Terms of Use